TD Cowen analyst Steven Mah lowered the firm’s price target on Amyris to $4 from $6 and keeps an Outperform rating on the shares. The analyst said they posted another revenue and earnings miss driven by smaller brands weakness due to the new focus on market-leading brands with a clear path to profitability, plus WC issues which affected order fulfillment.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMRS:
- Amyris price target lowered to $5 from $22 at H.C. Wainwright
- AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
- Amyris sees FY23 revenue growth 95%-100%, consensus $505.65M
- Amyris reports Q4 EPS (46c), consensus (27c)
- Amyris options imply 21.0% move in share price post-earnings